Fate Therapeutics, Inc.
FATE
$0.9205
-$0.0458-4.74%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/13/2025
-
MarketBeat
3/13/2025
-
Ticker Report
3/11/2025
-
MarketBeat
3/10/2025
-
The Fly
3/10/2025
-
MarketBeat
3/7/2025
-
MarketBeat
3/7/2025
-
MarketBeat
3/7/2025
-
MarketBeat
3/7/2025
-
Ticker Report
3/7/2025
-
MarketBeat
3/7/2025
-
TipRanks Financial Blog
3/6/2025
-
MarketBeat
3/6/2025
-
MarketBeat
3/6/2025
-
TipRanks Financial Blog
3/6/2025
-
Ticker Report
3/6/2025
-
TipRanks Financial Blog
3/6/2025
-
The Fly
3/6/2025
-
The Fly
3/6/2025
-
TipRanks Financial Blog
3/6/2025
-
TipRanks Financial Blog
3/5/2025
-
Zolmax
3/5/2025
-
Zacks Investment Research
3/5/2025
-
GuruFocus
3/5/2025
-
GuruFocus
3/5/2025
-
SeekingAlpha.com: All News
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, March 5, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
858 875 1800
Address
12278 Scripps Summit Drive
San Diego, CA 92131
San Diego, CA 92131
Country
Year Founded
Business Description
Sector
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The...
more
